Dr. Daniel K. Friedman, MD

Dr. Friedman practices at Tuality Anticoagulation Clinic - Anticoagulation - HOPD in Hillsboro, Oregon.

Dr. Friedman's NPI, 1619949658, was assigned on February 3, 2006. Dr. Friedman holds Oregon license 21727.

Dr. Friedman's primary practice is Tuality Anticoagulation Clinic - Anticoagulation - HOPD, at 364 SE 8th Ave, Hillsboro, OR 97123.

Dr. Friedman's primary practice is Tuality Anticoagulation Clinic - Anticoagulation - HOPD in Hillsboro, Oregon. Dr. Friedman is also affiliated with Hillsboro Medical Center. The medical group on file is Hillsboro Medical Center (Tuality Healthcare). Dmand AI also links Dr. Friedman to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account. Dr. Friedman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Friedman is licensed in Oregon.

CMS data shows 735 Medicare services from Dr. Friedman across 5 procedure codes in 2024, for 322 Medicare patients. Medicare paid $52,660 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 113 patients. 62% of them have high blood pressure, and 61% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 72, with 51% women.

In 2024, Dr. Friedman wrote 6,372 Medicare Part D claims for 703 patients. 92% of them were for generic drugs. CMS names the drug for 6,186 of them, across 75 drugs with 11 or more claims each, at $680,639 in total drug cost. In 2023, CMS named 4,916 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Friedman for performance year 2024, reported through an alternative payment model (APM). Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

CMS Open Payments shows 25 general payments to Dr. Friedman from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $111.